ARTICLE / CLIENT ALERT
A Federal Privacy Law or a False Hope? Making Sense of the American Privacy Rights Act of 2024 Draft
April 17, 2024
Read time: 11 min
On April 7, 2024, Rep. Cathy McMorris Rodgers (R-WA), the chair of the US House Committee on Energy and Commerce, and Sen. Maria Cantwell (D-WA), the chair of the US Senate Committee on Commerce, Science, and Transportation, unveiled a discussion draft of the American Privacy Rights Act of 2024 (APRA).
ARPA would establish a national consumer privacy and security standard. It would also have the effect of rendering moot the nearly 20 state consumer privacy laws that have been enacted to date. But APRA has a long, long way to go before it becomes law.
Scope and Applicability
If passed, APRA will apply to companies that determine the purpose and means of processing covered data and that are (i) subject to Federal Trade Commission (FTC) oversight, (ii) common carriers under the Communications Act of 1934 or (iii) a nonprofit organization. However, APRA would not apply to the following:
- “Small businesses”;
- Certain activities of fraud-related nonprofit entities;
- The National Center for Missing & Exploited Children;
- Government entities; or
- Nongovernment entities processing covered data on behalf of government entities in that capacity as covered entities.
A “small business” is an entity whose average annual gross revenue for the prior three years did not exceed $40 million, did not process the covered data of more than 200,000 individuals (with limited exceptions) and did not transfer covered data to a third party in exchange for anything of value.
The inclusion of nonprofits within the scope of APRA is a bit of a surprise given that most state consumer privacy laws exempt nonprofits from their scope.
Regulated Data
APRA would regulate “covered data,” which is information that identifies or is reasonably linkable to an individual or a device that identifies or is reasonably linkable to at least one individual. Covered data does not include deidentified data; employee information collected by the employer or their service providers; publicly available information; information available in a library, archive or museum (under certain circumstances); and inferences made exclusively from publicly available information.
Sensitive Covered Data
Sensitive covered data is a subtype of covered data, and it includes:
- Government-issued identifiers;
- Past or present mental or physical health information;
- Genetic information;
- Financial account numbers;
- Biometric information;
- Precise geolocation information;
- Private communications, including voicemails, emails, texts and direct messages;
- Information relating to an individual under the age of 17; and
- Information revealing an individual’s online activities over time, including across websites, online services not sharing common branding or online services operated by a “covered high-impact social media company.”
Companies would only be permitted to transfer sensitive covered data to third parties if they obtained affirmative express consent or if the transfer was for certain permitted purposes. Biometric and genetic information would be subject to additional restrictions and can only be processed for certain, expressly identified purposes. APRA would also restrict the collection and use of biometric and genetic information, making the continued use of the data by companies rather onerous, including, e.g., strict consent requirements and retention limits.
Consumer Rights
APRA would require covered entities to provide consumers with rights that should look familiar, except the right to opt out of “transfers” as described below:
- The right to access that consumer’s covered data in a readable format, or to receive a description of that data if the covered entity no longer has the data;
- The right to correct inaccuracies in covered data;
- The right to delete covered data;
- The right to export covered data. This right would not require a company to export derived data when it would reveal a trade secret or other confidential information; and
- The right to opt out from the transfer of covered data and from targeted advertising. Where a consumer opts out from a “transfer,” the company cannot disclose, release, share, disseminate, make available, sell, rent or license the covered data by any means for any commercial purpose, including compensation. This concept of allowing individuals to opt out of all “transfers” is much broader than what is provided for under existing state laws and seems difficult, if not impossible, to manage from an operational standpoint.
Required Disclosures
Companies would be required to publish a privacy policy containing:
- Identity and contact information of the company;
- Identities of any affiliates within the same corporate family to which covered data may be transferred, where that affiliate is not under common branding with the covered entity or has different contact information than the covered entity;
- A description of the categories of covered data and purposes of the processing;
- Information about covered data transfers, including categories of service providers and third parties to whom data is transferred, and an express identification of data brokers to whom covered data is transferred;
- The covered entity’s data retention practices related to covered data;
- A general description of the data security practices of the entity;
- A description of how the individual can exercise their data subject rights;
- The effective date of the privacy policy; and
- A statement as to whether the covered entity transfers, processes or retains covered data in or otherwise makes covered data accessible to a foreign adversary (as identified by the US secretary of commerce).
Data Minimization
Under APRA’s data minimization requirement, companies would not be allowed to process covered data beyond what is necessary, proportionate and limited to provide or maintain a specific product or service requested by the individual or to reasonably communicate with the individual. In particular, covered data could only be processed for certain permitted purposes, including to:
- Protect data security;
- Respond to an ongoing or imminent security incident;
- Prevent or respond to fraud;
- Comply with legal obligations;
- Prepare or defend legal claims;
- Transfer to law enforcement pursuant to a lawful warrant or subpoena;
- Conduct market research;
- Develop or enhance the company’s products or services, or conduct internal research to improve a product or service by using deidentified data;
- Transfer assets as part of a merger, acquisition or bankruptcy; or
- Provide first party or contextual advertising or, where the consumer has not opted out, targeted advertising.
APRA also would prohibit the use of “dark patterns” to divert a consumer’s attention from a required notice, impair a consumer’s ability to access their rights or facilitate an individual’s consent where required under APRA.
Under APRA, companies would be required to conduct written evaluations of algorithms using covered data prior to deploying the algorithms. The evaluation must be shared with the FTC and address the design, structure and inputs of the algorithm to reduce potential harm. The concept of “potential harm” is not limited to any specific types of harm and includes harms related to:
- Minors under 17 years of age;
- Advertising or determining access (or restrictions) related to housing, education, employment, healthcare, insurance or credit opportunities;
- Determining access (or restrictions) to places or public accommodations, particularly in relation to protected characteristics;
- Disparate impact on the basis of race, color, religion, national origin, sex or disability status; or
- Disparate impact based on political party registration status.
Large Data Holders
APRA includes additional requirements for “large data holders.” With some exceptions for conduit-type service providers (e.g., mail and payment services), large data holders are companies with an annual gross revenue of at least $250 million in the most recent calendar year that also collected, processed, retained or transferred covered data of at least five million individuals, 15 million portable connected devices reasonably linkable to at least one individual, and 35 million connected devices reasonably linkable to at least one individual; or collected, processed, retained or transferred the sensitive covered data of at least 200,000 individuals, 300,000 portable connected devices reasonably linkable to at least one individual, and 700,000 connected devices reasonably linkable to at least one individual.
Large data holders would be required to publish on their website a copy of each previous version of their privacy policy, along with a log of the material changes going back 10 years. Large data holders would also be required to provide a short-form privacy notice that includes an overview of individual rights and disclosures to reasonably draw attention to data practices that may be unexpected or that involve sensitive covered data. This short-form notice would have to be fewer than 500 words long.
Large data holders would also be required to conduct an annual impact assessment for any covered algorithm that poses a consequential risk of a potential harm described above. This assessment would include the following:
- A detailed description of the algorithm;
- A statement of the purpose and use of the algorithm;
- A detailed description of the data used by the algorithm;
- A description of the algorithm’s outputs;
- An assessment of the necessity and proportionality of the covered algorithm for its stated purpose; and
- A detailed description of the steps taken to mitigate the potential harms evaluated by covered entities.
Data Brokers
APRA also includes specific requirements for “data brokers.” Data brokers are covered entities that either:
- Earn at least 50 percent of their revenue from processing or transferring covered data that was not collected directly by the company from the relevant individual; or
- Earn any revenue from processing or transferring covered data of more than five million individuals that was not collected directly by the company from the relevant individual.
Data brokers would be required to maintain a publicly accessible website with a notice that the entity is a data broker and that individuals may exercise their data subject rights, with instructions for doing so. Data brokers would not be allowed to advertise or market access to covered data if the access is for a variety of purposes, including stalking, harassing, committing fraud, identity theft or unfair or deceptive acts or practices.
Data brokers would also be required to register with the FTC each year if they acted as a data broker with respect to at least 5,000 individuals or devices reasonably linkable to an individual in the previous year.
Enforcement
APRA would primarily be enforced by the FTC or state privacy regulators (attorneys general or otherwise) but does include a limited private right of action. The FTC would be required to establish a new bureau for the purpose of enforcing APRA.
Individuals could bring claims seeking actual damages, injunctive relief, declaratory relief, and reasonable attorney’s fees and litigation costs in certain, limited instances, including allegations that a company:
- Transferred sensitive covered data without affirmative express consent;
- Processed biometric or genetic information improperly;
- Provided inadequate privacy policy disclosures or failed to meet notification requirements;
- Failed to provide, recognize or operationalize data subject rights requests;
- Failed to provide opt-out rights or engaged in dark patterns;
- Retaliated through discriminatory pricing, quality or service levels;
- Failed to maintain reasonable security;
- Failed to exercise reasonable due diligence in selecting a service provider or transferring covered data to a third party;
- Failed to honor Do Not Collect requests as a data broker;
- Discriminated against individuals on the basis of race, color, religion, national origin, sex or disability; or
- Failed to provide, recognize or operationalize a consumer’s decision to opt out of the use of a covered algorithm.
Before filing suit, an individual would need to provide 30 days’ written notice to the company, identifying specific, alleged violations of APRA and give the company an opportunity to cure that violation.
Effective Date
APRA would be effective 180 days after its enactment. That is not a lot of time for companies to implement the sea change of requirements that APRA would usher in. However, as discussed below, the prospects of APRA becoming law are relatively low.
Preemption
If passed, APRA would expressly preempt most state privacy laws, transforming the patchwork system of state privacy laws into a single set of federal requirements. While preemption would simplify corporate compliance burdens, APRA is more operationally complex in many ways than the existing patchwork of state laws.
There are carveouts in APRA’s preemption provision for various specific laws, rules, regulations and requirements. Notably, employment-related health or medical privacy requirements are not preempted, which likely means that the California Consumer Privacy Act provisions as applied to employees and much of Washington’s My Health My Data Act would survive. In addition, APRA would not change the privacy requirements of other federal laws, including most notably requirements under the Health Insurance Portability and Accountability Act, the Gramm-Leach-Bliley Act or the Fair Credit Reporting Act.
So, You’re Saying There’s a Chance?
While APRA does have bicameral and bipartisan support, it is lacking key support – on both sides of the aisle – from legislators who previously supported other federal privacy proposals and who need to support APRA for it to have a real chance to pass.
Complicating matters further is the fact that it is a presidential election year. Historically, unless one party controls the legislature, very little impact legislation is passed in that setting, and there is nothing to signal that APRA will be an exception. For example, the inclusion of a private right of action in APRA will likely be a nonstarter for many in the House, while the state preemption provisions will jeopardize support of legislators from states that have enacted state consumer privacy laws, especially the support of California’s legislators.
If you have questions about the existing state privacy law requirements or other privacy concerns, please reach out to your McDermott lawyer or contact the authors.

Preparing for evolving cybersecurity threats
ARTICLE
Preparing for evolving cybersecurity threats
Apr 15, 2024
Read time: 5 min
The recent ransomware attack against the Duvel Moortgat Brewery demonstrated the very real risk that cybersecurity incidents pose to the alcohol industry, reportedly halting operations for several days at four of Duvel Moortgat’s facilities in Europe and the United States. This attack comes after other major alcohol producers experienced disruptive ransomware attacks in the last several years. Incidents like these can be devastating for a company’s business and reputation, and hackers’ strategies are constantly evolving to maximize their damage. But companies can be prepared with an information security program designed to prevent successful attacks and quickly respond if one occurs. Experienced partners such as McDermott are critical resources throughout this process, enabling companies to better update and fortify their security programs.
THE GROWING THREAT OF ATTACK
Hackers have extorted companies through ransomware attacks for decades, but hacker strategies have evolved to increase the risks to companies, often resulting in a larger ransom for the hacker. A “ransomware” attack traditionally refers to a strategy in which a hacker gains access to a victim’s computer system, encrypts the information on those systems and demands a ransom payment to unlock that information. Victims may try to avoid paying the ransom by restoring most of their systems from backups, but hackers have recently introduced additional strategies that can complicate that recovery. Today, hackers often try to steal the victim’s information before encrypting it on the victim’s system, so that they can sell or publish the information if the victim refuses to pay the ransom. Hackers also may try to “corrupt” backups so that the victim cannot effectively restore its system without the hacker’s assistance. One ransomware group, AlphV, says that it also reports its publicly traded victims to the US Securities and Exchange Commission if they don’t pay the ransom.
Determining whether to pay a ransom is a complicated decision, with either choice presenting notable risks. The ransom will likely be expensive and must be paid without any guarantee that the hacker will make good on its promises. The decryption software or key may not work, or the hacker may not delete information. One hacking group, LockBit, is believed to save victims’ information after their ransoms are paid despite promising to delete it. The hacker may be willing to negotiate a lower payment amount, but doing so takes valuable time while the victim’s systems likely remain nonfunctional. The hacker may be under sanctions, in which case paying the ransom would be illegal and could result in a fine for the victim. Paying the ransom rewards the hacker, which may increase the risk that the hacker targets the victim again. There is rarely a clear path back to safety after a successful breach, so it is important that the victim make an efficient, informed decision.
OPPORTUNITIES FOR PREPARATION AND PREVENTION
Companies can minimize these risks by maintaining a security program designed to prevent incidents from occurring and to effectively respond if they do occur. The security program should utilize administrative, technical and physical security policies and procedures to enable personnel to detect and report actual or suspended incidents, aggressively monitor the company’s systems for suspicious files and behavior and protect the company’s facilities from unauthorized intrusions. The security program must be regularly tested and updated to identify weaknesses, implement appropriate detection and response solutions, and plan for evolving hacker strategies and business demands. Incident response plans should be regularly tested to ensure that they accurately reflect the company’s resources and priorities and that the responders are prepared to execute the plan if necessary.
Companies should also leverage third-party professionals to improve the effectiveness of their preparation and response. These partners can provide specific knowledge and perspective to help the company appropriately plan for an incident without needing to experience an incident first. For example, an experienced law firm such as McDermott can advise the company on its legal obligations, help identify and address risks in a security program, and investigate and respond to an incident, all while protecting the company’s privilege. By leveraging this support early, a company can find and address its weaknesses before they are exploited, better understand other companies’ approaches to these issues, and ensure that its partners are aligned on the company’s priorities. In the event of an incident, an effective third-party partner can efficiently advise victims on their obligations, options and risks; provide additional resources for a busy team; and help prioritize response activities based on the needs of the business.
CONCLUSION
Cybersecurity incidents can quickly become expensive, complicated and devastating for victims. Hackers are continuously improving their methods for obtaining larger ransoms, and after an incident has started, the victim often has no way of ensuring that it can completely remediate the problem. Companies can limit their risks by instituting systems to protect against threats and prepare to respond to any incident that arises. Companies should also consult with external professionals regularly to evaluate and improve their protections and ensure that their security program does not become outdated.

The Impact of the New EU AI Act on the Medtech and Life Sciences Sector
ARTICLE / CLIENT ALERT
The Impact of the New EU AI Act on the Medtech and Life Sciences Sector
April 15, 2024
Read time: 9 min
As technology continues to advance almost every aspect of healthcare, so the use of AI has become an increasing focus for developers and the regulators who are racing to keep pace with rapid advancements in technology.
Software (including AI) with a medical purpose is already regulated in Europe and the United Kingdom as a medical device and requires comprehensive assessment before it can be placed on the market under EU Medical Device Regulations 2017 (MDR) and the EU In Vitro Diagnostic Medical Devices Regulation (IVDR).
Despite the existing comprehensive regulatory requirements, there has been concern that the current framework does not fully address the ethical and transparency risks associated with AI. The European parliament is leading the way with the Act, which applies to all sectors but will have significant implications in the life sciences sector, particularly for AI medical device manufacturers. Find our general overview of the Act in our client alert, “The AI Act: The EU’s bid to set the global standard for AI regulation.”
Like the General Data Protection Regulation, the Act has global reach; it will apply to providers wherever they are in the world if they place, or put into service, an AI system in the European Union. The Act is also only one piece in the puzzle of new AI-related legislation and will need to be read in the context of changes proposed on product liability and AI liability.
Defining an AI System
Over the last few years, it has become popular to describe technologies as artificial intelligence, even where the software may be a fixed or locked algorithm with no adaptiveness.
It will now be important for manufacturers to determine whether their software are truly AI systems with the scope of the Act, which defines an AI system as:
“A machine-based system designed to operate with varying levels of autonomy, that may exhibit adaptiveness after deployment and that, for explicit or implicit objectives, infers, from the input it receives, how to generate outputs such as predictions, content, recommendations, or decisions that can influence physical or virtual environments.”
The key term here, “infer” is not precise, but the recitals to the Act give helpful context about how it should be interpreted, stating that AI does not include systems based on rules defined solely by natural persons to automatically execute operations. In other words, the Act does not appear to apply to software comprised of rules-based fixed algorithms. Systems that go beyond basic data processing and enable learning, reasoning, or modelling are, however, likely to be caught.
The line here may not always be clear cut, and it appears that the Act will not apply to many current “AI” solutions, which operate using fixed diagnostic algorithms rather than independent or self-learning capabilities, although stabilised systems with incremental learning may be caught.
High Risk AI Systems
Under the Act, any AI system that is a Class IIa (or higher) medical device, or uses an AI system as a safety component, is designated as “high risk”.
The Act also specifies certain types of healthcare AI systems as high risk, whether or not they are medical devices, such as AI systems used by public authorities to evaluate the eligibility of people for essential public services, and AI systems that are emergency healthcare patient triage systems.
What AI Medical Device Providers Need to Know
Under the AI Act, high-risk AI systems will need to comply with a raft of additional requirements, many of which overlap with the current rigorous requirements of conformity assessment under the MDR and IVDR
These entirely new requirements include a conformity assessment by a notified body that the AI system meets the requirements under the AI Act, including with respect to the technical documentation and risk management system. During the development of the legislation, there was concern that this “double certification” would lead to significant delay of market entry and double running cost for device manufacturers. The legislators have accommodated these concerns, in part. For medical devices, the Act states that the conformity assessment procedure in the MDR and IVDR must be followed, and that the requirements of the Act will be part of that assessment.
The Act also allows medical device notified bodies to carry out AI conformity assessments, provided that their AI competence has been assessed under the MDR and IVDR. In other words, a single declaration of conformity is proposed, although the precise mechanics for this remain unclear.
Given the well-publicised lack of notified body capacity in the run-up to the implementation of the MDR and IVDR, medical device manufacturers will naturally be concerned to ensure that their existing notified body has been assessed as competent to conformity assess AI systems. If two notified bodies are required, that may risk divergent views on how the same or similar requirements are to be met.
Many of the requirements in the Act also replicate existing requirements in the EU MDR and EU IVDR. For example, the requirements to have a quality management system, technical documentation, and instructions for use.
The AI Act contemplates a single set of technical documentation to include all the requirements, both under the EU MDR and the EU AI Act. However, medical device manufacturers that have already certified their devices under the EU MDR, may need to amend their technical documentation to reflect the additional requirements of the EU AI Act.
Additional requirements for AI systems that are not already in the EU MDR and the EU IVDR, include:
- Governance and data management requirements for training and testing data sets
- New record-keeping requirements, including the automatic recording of events (logs) over the system’s lifetime
- Transparent design requirements so deployers can interpret the output and use it appropriately
- Human oversight design requirements
- Accuracy and cybersecurity requirements.
Where medical device manufacturers are providers or deployers of general-purpose AI models or systems, they will also need to comply with these requirements.
Although legislators have made efforts to attempt to streamline overlap between regulatory frameworks, many questions remain. For example, it is not clear how the substantial modification framework under the AI Act will interact with the MDR and IVDR modification rules. Likewise, it is not clear whether devices undergoing a trial (performance evaluation or clinical investigation) will need to be AI Act certified prior to use in the trial.
The Act proposes harmonised standards, but it is not currently clear whether these will overlap or differ from current harmonised standards, such as ISO 13485.
The industry will be keen to see the guidance on these points, and to understand whether the costs and time of a second certification present a barrier to market entry of the most innovative products.
The Impact on Deployers of High Risk AI Systems
Unlike the MDR and IVDR, which place responsibilities on economic operators in the supply chain, the AI Act also puts responsibilities onto the deployers of AI systems, being any person using an AI system in the course of a business or professional activity, such as hospitals or clinicians. These deployers will have new obligations, including:
- Taking appropriate technical and organisational measures to ensure that AI systems are used in accordance with their instructions for use
- Assigning human oversight to competent, trained people
- Monitoring and surveillance
- Maintaining system logs when these are under their control
- Undertaking, where applicable, data protection impact assessments.
Impact on the Use of AI Systems in the Wider Life Sciences Sector
There is increasing use and development of AI systems and models across the medicine product lifecycle; from drug discovery, through to clinical trial recruitment, and post market vigilance activities.
Many of these AI systems are unlikely to be medical devices because they do not have an intended medical purpose or are not designated as high risk under AI Act. The Act imposes only relatively lightweight obligations on the providers of these systems, such as requirements to ensure a sufficient level of AI literacy of their staff (including training), and certain transparency requirements.
Many pure scientific AI applications may also benefit from an exception from the AI Act. The EU Parliament has indicated that the intention of the Act is to support innovation, and the Act exempts AI systems, including their output, that were specifically developed and put into service for the sole purpose of scientific research and development.
This exemption may be helpful for life sciences companies at the early stages of research, but it is not yet clear how the term “scientific research” will be interpreted and whether this exemption will only apply to academic, as opposed to commercial research.
Although life sciences companies may welcome the light touch approach under the AI Act, this is unlikely to be the end of the story for AI systems used in medicinal development.
In December 2023, EMA published a five year workplan setting out its key work streams for its strategy on AI. This built on the draft reflection paper issued in 2023, which was published for consultation on the use of AI in the lifecycle of medicinal products. This draft paper emphasised that marketing authorisation holders and applicants are responsible for ensuring that any AI used to support the development of a drug complies with existing requirements, such as good practice (GxP) and European Medicines Agency scientific guidelines. The reflection paper also outlined various use cases for AI across the product lifecycle and gave indications of risk for AI used at various stages.
According to the workplan, further AI guidance and the reflection paper are due to be published in 2024 and 2025.
Implementation Timeline
The AI Act is likely to enter into force later this year, with a phased implementation period, followed by a phased transition period, before becoming enforceable. Obligations for high-risk AI systems already covered by other EU regulation, such as medical devices, will only come into force 36 months after the Act enters into force.
Whilst this is a relatively generous period, it is worth bearing in mind that the MDR and IVDR had longer implementation periods, and in both cases, these have now been extended.

The SEC and CFTC Overhaul Form PF
ARTICLE / CLIENT ALERT
The SEC and CFTC Overhaul Form PF
April 15, 2024
Read time: 26 min
The US Securities and Exchange Commission (“SEC”) and the Commodity Futures Trading Commission (“CFTC”) have overhauled Form PF and private fund managers have until March 12, 2025, to begin reporting on the new Form. The changes to the reporting requirements mandated by the amendments to the Form (“Form PF Amendments”) will require substantial preparation by many managers.[1]
The Form PF Amendments are designed to enhance both the SEC’s and the Financial Stability Oversight Council’s (“FSOC”) monitoring of systemic risk, and strengthen the regulatory oversight of private funds and investor protection efforts.[2] The Form PF Amendments were jointly adopted by the SEC and CFTC on Feb. 8, 2024, with the Chairman of the SEC, Gary Gensler, noting “since Form PF first was adopted [12 years ago], the SEC, CFTC, and FSOC have identified gaps in the information . . . from private fund advisers . . . and amendments . . . will enhance the [SEC’s, the CFTC’s,] and [the] FSOC’s understanding of the private fund industry as well the potential systemic risk posed by the industry and its individual participants. In addition, the adoption also furthers investor protection efforts.”
Form PF is the reporting form used by certain SEC-registered investment advisers to private funds, including those that also are registered with the CFTC as a commodity pool operator or commodity trading adviser. The Form PF Amendments change how large hedge fund advisers report the following, among other changes:
- Investment exposures;
- Borrowing and counterparty exposure;
- Market factor effects;
- Currency exposure;
- Turnover;
- Country and industry exposure;
- Central clearing counterparty reporting;
- Risk metrics;
- Investment performance by strategy;
- Portfolio liquidity; and
- Financing and investor liquidity.
In addition, the Form PF Amendments require additional basic information about advisers and the private funds that they advise, including identifying information, assets under management, withdrawal and redemption rights, gross asset value and net asset value, inflows and outflows, base currency, borrowings and types of creditors, fair value hierarchy, beneficial ownership, and fund performance.
The Form PF Amendments come just two months after the Dec. 11, 2023 effective date for the majority of the requirements under the Form PF event-based reporting amendments finalized by the SEC in May 2023.[3]
This Alert outlines certain key changes to Form PF reporting requirements under the Form PF Amendments, as well as the potential burden on private funds to revise their reporting processes to comply with the Form PF Amendments.
Amendments to General Instructions – Impact on all Filers
The Form PF Amendments include significant changes to the Form PF General Instructions, which apply to all Form PF filers and are intended to improve data quality and comparability and to enhance systemic risk assessment. The amendments to the General Instructions include:
1. Separate Reporting for each Component Fund of a Master-Feeder and Parallel Fund Structure: The Form PF Amendments’ most substantial change is the new requirement to separately report each component fund of a master-feeder arrangement or parallel fund structure, other than a feeder fund that invests all of its assets in a single master fund, US treasury bills, and/or cash and cash equivalents (defined as a “disregarded feeder fund”).
Currently, Form PF allows for advisers to respond to questions regarding master-feeder arrangements and parallel fund structures either in the aggregate or separately, as long as they do so consistently throughout the Form.[4] The SEC was reluctant to prescribe such an approach in 2011 when Form PF was originally adopted, citing the potential burden on advisers as part of the reporting framework. In the adopting release for the Form PF Amendments (“Adopting Release”), the SEC explained that given the disparities in approaches between Form PF filers, certain risk profiles with respect to asset size, counterparty exposures and/or investor liquidity have been obscured, and separate reporting will improve data quality and comparability and enhance systemic risk assessment.[5]
While advisers will now be required to report separately each component fund of a master-feeder arrangement and parallel fund structure, advisers will continue to aggregate these structures for purposes of determining whether the adviser meets a reporting threshold (e.g., in determining if the adviser is a large hedge fund adviser).[6] In explaining how disaggregated reporting will improve the identification of risk exposures, the SEC provided an example where a feeder fund may have counterparty exposure, rather than the entire fund in the aggregate, as fewer assets held at the feeder fund level would be available as collateral and the counterparty may have greater risk.[7]
As noted above, there is a carve out from the separate reporting requirement for a “disregarded feeder fund”, which is a feeder fund that invests all of its assets in (i) a single master fund, (ii) US treasury bills, and/or (iii) cash and cash equivalents.[8] Advisers will identify a disregarded feeder fund and look through to any disregarded feeder fund’s investors in responding to certain questions regarding the master fund’s investors (e.g., beneficial ownership).[9] The SEC views a disregarded feeder fund as not meaningful for data analysis as the master fund is the conduit through which investment is made, and such master fund’s activity is captured via the Form.[10]
Advisers will continue to aggregate master feeder arrangements and parallel fund structures for purposes of determining whether the adviser meets a reporting threshold (e.g., in determining if the adviser is a large hedge fund adviser). However, the SEC adopted instructions stating that advisers should disregard the holdings of feeder funds in their respective master fund’s equity for the purposes of determining whether the master-feeder arrangement compromises a qualifying hedge fund, as this will avoid potential double counting.[11]
Unchanged from the current Form PF, dependent parallel managed accounts must be aggregated with the largest private fund to which it relates. Advisers will continue to be required to report the total value of all parallel managed accounts related to each reporting fund.
In justifying this change to require separate reporting, the SEC explained that such reporting would not be overly burdensome since advisers already assemble aggregated data for determining Form PF reporting categories, and any additional burdens are justified to increase transparency and systemic risk monitoring.
2. Investments in other private funds (“fund of funds”): Currently, advisers include the value of their private funds’ investments in other private funds when determining whether the adviser meets the threshold to file Form PF. Currently, Form PF also generally allows an adviser to disregard the value of equity investments in other private funds for purposes of both the Form’s reporting category thresholds (e.g., whether it qualifies as a large hedge fund adviser) and responding to certain questions on Form PF, as long as the reporting is done consistently throughout the Form subject to certain exceptions.[12]
The Adopting Release retains this flexibility to allow advisers to continue to include or exclude the value of such investments. However, the SEC opted to amend Instruction 7 of the Form PF General Instructions to include with more explicit language that requires advisers to include the value of their investments in private funds – whether internal or external – in determining whether the adviser is required to file Form PF; whether it meets the thresholds for reporting as a large hedge fund adviser, large liquidity fund adviser, or large private equity fund adviser; and whether a hedge fund is a qualifying hedge fund.[13]
In explaining these changes, the SEC noted that the current flexible standard provides unclear and inconsistent reporting and data on the scale of a reporting fund’s exposures. Disagreeing with a number of commentors regarding the increased burden of reporting such information, the SEC remarked that advisers are currently required to include investments in other private funds to determine whether they meet the Form PF filing threshold and fund-of-funds structures present risks because they are engaged in direct investments.
The SEC retained elements of the instruction allowing for funds that invest substantially all of their assets in other private funds (and only holds cash and cash equivalents and instruments acquired for the purpose of hedging currency exposure) to only complete Section 1b of the Form, and not Section 1c. While the SEC generally retained this exclusion, it modified the instructions to change the language from “substantially all” to “80% or more of its assets.”[14]
Currently, advisers are not required to, but nonetheless have the option to, “look through” a reporting fund’s investments in any other entity (including other private funds), which the SEC commented has led to inconsistent data and comparisons. As a result, Instruction 7 of the Form PF General Instructions was amended further to require advisers to “look through” a reporting fund’s investments in internal or external private funds (other than a trading vehicle), unless the question instructs the adviser to report exposure obtained indirectly through positions in such funds or other entities. The instructions were modified to require advisers that cannot avoid “looking through” to the reporting fund’s investments in internal private funds or external private funds to include an explanation in response to Question 4.[15]
3. Trading Vehicles: Currently, Form PF does not require advisers to report separate legal entities wholly or partially owned by private funds that hold assets, incur leverage, or conduct trading or other activities as part of the private fund’s investment activities, but do not operate a business (a “trading vehicle”). Given the fact that trading vehicles aren’t currently identified, there is a blind spot for the SEC, with the Adopting Release stating “Form PF does not provide a clear window into the existence or use of trading vehicles and the risks they may present.”
The Form PF Amendments require advisers to identify and report information on any trading vehicles of the reporting fund, regardless of whether the trading vehicle is wholly owned or partially-owned. The types of information that advisers will be required to report include how the reporting fund uses the trading vehicle, position sizes, and counterparty exposures of the reporting fund that are attributable to the trading vehicle. The Form PF General Instructions were also amended to explain how advisers will report information if the reporting fund uses a trading vehicle – specifically, if the adviser uses a trading vehicle, it will be required to be identified in Section 1b and report answers for it and the fund on an aggregated basis.[16]
While reporting will be done on an aggregated basis, the Form PF Amendments add specific questions to Form PF that are designed to assist the SEC in understanding the use of such trading vehicles and identify risk exposures. This approach, the Adopting Release stated, will help differentiate this level of reporting from that of the reporting fund and emphasized the importance of this information to provide more complete and accurate visibility into asset class exposures, position sizes, counterparty exposures relied on by trading vehicles, and systemic risk monitoring generally.
4. Report Timing: To harmonize reporting information, large hedge fund advisers and large liquidity fund advisers will be required to update Form PF within a certain number of days after the end of each calendar quarter, rather than each fiscal quarter. All other advisers will continue to make annual filings within the prescribed timeframe following the end of their fiscal year. Additionally, all advisers will use fiscal quarters and years, when relevant, to determine whether they are meeting filings thresholds.[17]
The SEC cited disparities in the timing of reporting across this category of advisers and the potential delays in seeing comprehensive data across similarly situated funds. Analyzing Form ADV data as of December 2022, the SEC noted that 0.4 percent of large hedge fund advisers and large liquidity fund advisers do not file on a calendar quarter basis, equating to about 224 private funds. Based on the SEC’s own data, only a de minimis segment of advisers will be impacted by this change. Nonetheless, the SEC noted that discrepancies in reporting time creates gaps in completeness of information they receive at a particular time, thus degrading their data analysis and comparison capabilities. In its first reference to the CFTC in the Adopting Release, the SEC also noted that calendar reporting aligns with the CFTC’s CPO-PQR reporting, allowing easier integration of data sets.
The Form PF Amendments do not impact private equity fund advisers who will continue to file any required quarterly private equity Section 6 event-based reports (adviser-led secondaries, removal of adviser as GP, etc.) on a fiscal quarter basis.
Amendments to Section 1
Advisers required to file Form PF must complete some or all of Section 1 with respect to the private funds it advises. Section 1 of Form PF includes certain identifying and demographic information. The Adopting Release states that the amendments to Section 1 are designed to (i) provide greater insight into private funds’ operations and strategies, (ii) assist in identifying trends, (iii) improve comparability across advisers, (iv) improve data quality, and (v) reduce reporting errors. A number of amendments have been made to Section 1, and we have highlighted the notable amendments below:
- Withdrawal or Redemption Rights (Section 1b)
Currently, Form PF requires that only large hedge fund advisers report whether their qualifying hedge fund(s) provide investors with withdrawal or redemption rights “in the ordinary course.”[18] The Form PF Amendments require all advisers to respond to Question 10(a) or 10(b), which require the adviser to disclose whether the reporting fund is an “open-end private fund” in Question 10(a) or a “closed-end private fund” in Question 10(b). The SEC adopted newly defined terms for “open-end private fund” and “closed-end private fund” related to Question 10.[19]
If the reporting fund is an open-end private fund, the adviser will be required to disclose (i) how often withdrawals or redemptions are permitted by selecting a response from a list of categories (in Question 10(c)) and (ii) what percentage of the reporting fund’s net asset value may be, or is, subject to a suspension of, or material restrictions on, investor withdrawals/redemptions by an adviser or fund-governing body pursuant to Question 10(d).
Advisers that disclose in Question 10 that the reporting fund is neither an open-end private fund nor a closed-end private fund are required to provide a “detailed explanation” in their response to Question 4. These amendments are intended to improve data quality by more precisely classifying how an adviser should report on funds that offer limited withdrawal or redemption rights. The SEC notes, in a carryover from the May 2023 amendments to Form PF, that information on redemption rights will allow for SEC and FSOC to analyze stress or potential strategies that may be exacerbated by or result in fund failure based on investor redemptions.
2. Gross Asset Value and Net Asset Value (Section 1b)
Large hedge fund advisers and large liquidity fund advisers will be required to report their monthly net asset value and gross asset value. However, to address comments regarding the potential burden of monthly gross and net asset value calculations, advisers may use the reporting fund aggregate calculated value (“RFACV”) and newly defined gross reporting fund aggregate calculated value (“GRFACV”), or the newly defined “gross reporting fund aggregate calculated value” (“GRFACV”), if the adviser does not calculate GAV or NAV on a monthly basis. This additional information will be reported as of the end of each month of the reporting period in the quarterly filings, rather than only reporting the information as of the end of the reporting period, as Form PF currently requires.[20]
Advisers should note the carryover of the RFACV framework from the May 2023 event-based reporting amendments. Importantly, GRFACV (and RFACV) may be calculated using the adviser’s or its service provider’s methodologies, provided they are consistent with information reported internally. Advisers will need to indicate the methodology used to report in Questions 11 and 12.
The Form PF Amendments added new Question 13, which requires advisers to separately report the value of unfunded commitments included in the net and gross asset values reported in Questions 11 and 12. The asset value calculations in Questions 11 and 12 should include unfunded commitments, so that Form PF data is comparable to Form ADV data.
3. Inflows and Outflows (Section 1b)
Currently, large hedge fund advisers only report changes in inflows or outflows on an annual basis, which, the Adopting Release notes, causes this data to be stale and less effective than more frequently reported data for monitoring systemic risk. The SEC also stated that they’re currently unable to differentiate between changes in value resulting from performance and changes in value resulting from inflows and outflows.
In response, the newly added Question 14 now requires large hedge fund advisers and large liquidity fund advisers to report information concerning the reporting fund’s inflow and outflow activity, including contributions to the reporting fund, as well as withdrawals and redemptions, or other distributions of any kind to investors for each month of the reporting period. Advisers must include all new contributions from investors and exclude contributions of committed capital that they have already included in gross asset value calculated in accordance with Form ADV instructions. Here again, these amendments entail the SEC obtaining additional data throughout the reporting period by requiring this monthly data.
4. Fund Performance (Section 1b)
The Form PF Amendments redesignate current Question 17 as new Question 23, which requires all advisers to provide gross and net fund performance “as reported to current and prospective investors, counterparties, or otherwise” for specified fiscal periods using the table provided in Form PF. Advisers must report performance as a money-weighted internal rate of return (instead of a time-weighted return), if the reporting fund’s performance is reported to investors, counterparties or otherwise as an internal rate of return since inception. Whether the adviser uses a time-weighted or money-weighted rate of return, the methodology used should be consistent over time.
If the adviser does not provide net performance or gross performance information to investors, counterparties, or otherwise, then they will be required to provide the most representative set of performance information (if the adviser reports different fund performance results to different groups), with an explanation of its selection to be provided in Question 4.
The SEC acknowledged the potential inconsistencies between this new requirement for reporting fund performance on Form PF and certain other performance reporting rules. First, the SEC noted that quarterly performance reporting is required under the Private Fund Adviser Rule (“PFAR”), but did not address how PFAR reporting should or would be reflected in Form PF. For example, it is conceivable that an adviser’s quarterly performance reporting pursuant to PFAR could use an alternate methodology from that of Form PF. The SEC also acknowledged that calculations of net and gross performance for Form PF may treat fees and expenses differently than the calculation of net and gross performance under the Marketing Rule, but notes that different audiences are receiving this reporting.
5. Investment Strategies (Section 1c)
The Form PF Amendments to the investment strategies disclosed in Section 1c require the disclosure of more granular strategies for both equity and credit (e.g., private credit and associated sub-strategies, such as direct lending) to both account for the SEC’s evolved understanding of hedge fund strategies and to improve data quality and comparability.
The adviser must choose the investment strategies that best describe the reporting fund’s investment strategies, as of the last day of the reporting period, to account for intra-quarter changes to strategy. If the adviser selects “other” they’ll need to describe their strategy and why none of the available categories are sufficient.[21] The strategy disclosed in Section 1c should be consistent from one reporting period to the next.
Notably, the SEC included both “digital assets” and “litigation finance“ as reportable investment strategies in Section 1c, serving as an acknowledgment by the SEC that investment strategies are not static and that they may evolve based on technological changes and industry trends. With respect to “digital assets,” the SEC stopped short of defining the term for Form PF reporting purposes, but did acknowledge the prevalence of funds employing such strategies and its status as an asset class. With regard to the addition of “litigation finance” as a reportable investment strategy, the SEC noted that its addition to Section 1c, as well as other more granular categories for credit strategies, are meant to allow the SEC and FSOC to “conduct more targeted analysis and improve comparability among advisers and hedge funds, which the [SEC] and FSOC can use to identify and address systemic risk and investor protection issues in times of stress more accurately.”[22]
6. Counterparty Exposure (Section 1c)
Counterparty exposures is one of the key areas of focus for the SEC and FSOC for purposes of systemic risk monitoring. These Form PF Amendments are fairly extensive and include a new Question 26, which requires advisers (other than qualifying hedge funds) to complete a consolidated counterparty exposure table regarding exposures the adviser has to creditors/counterparties, and the exposures that creditors/counterparties have to the adviser.
Advisers will be required to report the dollar value of borrowing and collateral received and lending and posted collateral. The Form PF Amendments introduce newly defined terms, “borrowing and collateral received (B/CR)” and “lending and posted collateral (L/PC)”, with the SEC stating that these definitions are based on their understanding of borrowing and lending and helps ensure data quality and comparability. Current Questions 22 and 23 have been redesignated as Questions 27 and 28, and now provide more detailed instructions for advisers to use when identifying the individual counterparties, as well as the entity that has the reported exposure. Question 27 requires advisers to identify each creditor or other counterparty (including central clearing counterparties) that owes an amount (before posted collateral) equal to or greater than either (1) five percent of NAV as of the data reporting date or (2) $1 billion. Question 28 requires advisers to provide information for counterparties where the fund has net mark-to-market counterparty credit exposure which is equal to or greater than either (1) five percent of NAV or (2) $1 billion, after taking into account collateral received or posted by the reporting fund.
Qualifying hedge funds will complete similar counterparty exposure questions in Section 2. Together, the questions in Section 1c and similar questions at Section 2 will allow the SEC and FSOC to consolidate information relating to hedge funds’ and qualifying hedge funds’ arrangements with creditors and other counterparties.
Amendments to Section 2
The SEC rearchitected Section 2, which applies to large hedge fund advisers, as indicated in the chart below:

The additional information large hedge fund advisers will be required to disclose in amended Section 2 is intended to, among other things, provide further insight into the operations and strategies of qualifying hedge funds and their advisers. Below are some of the notable amendments captured in Section 2:
- Separate Reporting for Positions Held Physically, Synthetically or Through Derivatives & Indirect Exposure
The Form PF’s current instructions (and the associated definitions) require advisers to combine exposures held physically, synthetically, or through derivatives when reporting certain fixed income and other sub-asset classes. The current Form PF reporting requirements, which allow advisers to aggregate their physical and synthetically held positions, as well as long and short exposures, obscures the SEC’s understanding of the fund’s overall exposure because of the risk differences between such holdings, which reduces the SEC’s and FSOC’s ability to effectively assess systemic risk.
Advisers will now be required to report the dollar value of a qualifying hedge fund’s long and short positions in certain sub-asset classes by “instrument type” for each month of the reporting period. These amendments introduce more granular information as advisers will separately report long and short positions in these sub-asset classes held physically, synthetically or through derivatives, and indirectly through certain entities.
2. Adjusted Exposure Reporting
Currently, advisers report “gross” long and short exposure (i.e., the dollar value of a qualifying hedge fund’s long positions and short positions for various sub-asset classes). While retaining this reporting, the amendments require advisers to also report the “adjusted” exposure of long and short positions for each sub-asset class in which a fund has a reportable position. The inclusion of adjusted exposure reporting is intended to provide an additional datapoint and view into underlying risk exposures, the SEC noting that gross exposure could lead to potential false indicators of long/short exposure not representative of the actual economic exposure and market risk of a reporting fund’s portfolio.
3. Open and Large Positions
Open and large positions were called out by Chair Gensler in his statement on the adoption of the Form PF Amendments, noting that “the final rules will expand reporting requirements about a large hedge fund’s open positions and certain large positions. These requirements will provide insight into the extent of a fund’s portfolio concentration and large exposures to any specific assets. Such concentration or exposure may increase the risk of amplified losses for investors. Gathering additional data on concentration and exposure will help to protect investors and assess systemic risk.”
Advisers to qualifying hedge funds will be required to report their top five long and short netted positions and the top ten netted long and short positions. Additionally, advisers will provide more information regarding the total number of reference assets for the fund’s long and short netted exposure, and relative percentages of NAV based on these long and short netted exposures.
Advisers will also be required to provide certain information on a fund’s reference asset to which the fund has gross exposure equal to or exceeding certain thresholds (e.g., 1 percent of NAV). These amendments are intended to provide a more holistic view of the reporting fund’s portfolio concentration.
4. Counterparty Exposure and Significant Counterparty Reporting
The Form PF Amendments will require qualifying hedge funds to report counterparty exposures using a new consolidated counterparty exposure table (similar to the new consolidated counterparty exposure table adopted in Section 1c), which will capture all cash, securities, and synthetic long and short positions by a reporting fund, a fund’s credit exposure to counterparties, and amounts of collateral posted and received.
This consolidated counterparty exposure table replaces the information currently required by Questions 43, 44, 45, and 47 of the current Form PF, and requires, among other things, that advisers report the qualifying hedge fund’s borrowings and other transactions with creditors and other counterparties by type of borrowing or transaction (e.g., unsecured, secured borrowing and lending under a prime brokerage agreement, etc.) and the collateral posted or received by a reporting fund in connection with each type of borrowing or other transaction.
The new consolidated counterparty exposure table is designed to capture information on all non-portfolio credit exposure that a qualifying hedge fund has to its counterparties (including CCPs) and the exposure that creditors and other counterparties have to the fund.
For each qualifying hedge fund, advisers will also be required to identify all creditors and counterparties (including CCPs) where the amount a fund has borrowed (including any synthetic long positions) before posted collateral is equal to or greater than certain thresholds. For the top five creditors and other counterparties from which the fund has borrowed the most, advisers will be required to identify the counterparty (by name, LEI, and financial institutional affiliation) and provide information detailing a fund’s transactions and the associated collateral.
Questions 42 and Question 43 will require the disclosure of information about a reporting fund’s key individual counterparties (including CCPs) to which the fund has net mark-to-market counterparty credit exposure, as well as counterparties to which the reporting fund has net mark-to-market exposure above certain thresholds.
5. Additional Exposure Reporting
- Currency Exposure Reporting – The Form PF Amendments create new Question 33, requiring large hedge fund advisers to disclose (1) the net long value and short value of a fund’s currency exposure arising from FX derivatives and all other assets and liabilities and (2) each currency to which the fund has long or short dollar value exposure equal to or exceeding certain thresholds.
- Turnover – The Form PF Amendments will require disclosure on a per-fund basis of the value of turnover in certain asset classes (rather than on an aggregate basis as currently required). The amendments include new categories for turnover reporting that disaggregate combined categories and better capture turnover of potentially relevant securities (such as various types of derivatives).
- Country and Industry Exposure – The Form PF Amendments will require advisers to provide information about each country or industry to which a reporting fund has exposure equal to or exceeding certain thresholds.
Effective and Compliance Dates
The effective date and compliance date of the Form PF Amendments is March 12, 2025. The SEC noted that the one-year implementation timeline would “provide time for advisers to prepare to comply with the amendments, including reviewing the requirements, building the appropriate internal reporting and tracking systems, and collecting the required information, as well as to simplify the compliance process and reduce potential confusion . . .”[23]
While advisers may well be fatigued by the abbreviated six-month timeline to implement the Form PF event-based reporting amendments, advisers should consider discussing implementation plans, including creating internal working groups across the various departments/functions (e.g., legal, compliance, operations, finance, etc.), as well as early outreach and coordination with service providers.
Given the SEC’s prodigious rulemaking and other rule implementations to balance, private fund advisers should not view the one-year timeframe as a means to delay, as these amendments will result in a marked change from current Form PF reporting requirements.
Authored by Michael S. Didiuk, Malik Rollins and Joseph Daly.
If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.
[1] Form PF; Reporting Requirements for All Filers and Large Hedge Fund Advisers, 89 FR 17984 (March 12, 2024).
[2] See Securities and Exchange Commission, Final Rules, Form PF; Reporting Requirements for All Filers and Large Hedge Fund Advisers, Release No. IA-6546; (Feb. 8, 2024) (hereinafter, Final Rules).
[3] See Form PF; Event Reporting for Large Hedge Fund Advisers and Private Equity Fund Advisers; Requirements for Large Private Equity Fund Adviser Reporting, Release No. IA-6297; (May 3, 2023); Schulte Roth & Zabel, Alert: SEC Form PF Reporting Changes Effective Dec. 11, 2023, and June 11, 2024 (June 21, 2023), available here.
[4] See Final Rules at 12.
[5] See id.
[6] See id.
[7] See id. at 13.
[8] The current definition of “cash and cash equivalents includes “government securities” and Form PF defines “government securities” as (1) U.S. Treasury securities, (2) agency securities, and (3) any certificate of deposit for any of the foregoing. The Form PF Amendments revise the definition of “cash and cash equivalents” by removing “government securities” from the definition of “cash and cash equivalents.” The Form PF Amendments present “government securities” as its own line item in the Form PF Glossary of Terms. Further, the SEC adopted an amendment that directs advisers to exclude digital assets when reporting “cash and cash equivalents.”
[9] In the case of a disregarded feeder fund in Question 6 of amended Form PF, advisers instead will identify the disregarded feeder fund and look through to any disregarded feeder fund’s investors in responding to certain questions regarding fund investors on behalf of the applicable master fund.
[10] See Final Rules at 13.
[11] See Instruction 6 of the amended Form PF General Instructions.
[12] See Final Rules at 19-20.
[13] See id. at 20.
[14] See id. at 24.
[15] See id. at 24-25.
[16] See id. at 26-27 (Specifically, the Form PF Amendments revise Instruction 7 and 8 to require advisers to include information pertaining to their trading vehicles when completing Form PF.)
[17] See id. at 31.
[18] See Form PF; Event Reporting for Large Hedge Fund Advisers and Private Equity Fund Advisers; Requirements for Large Private Equity Fund Adviser Reporting, Release IA-6297; (May 3, 2023), at Section 2b, Question 49.
[19] See Final Rules at 69; 83.
[20] See id. at 51-52.
[21] The SEC cited that the amount of hedge fund exposure that advisers attribute to the “other” category has grown by 30 percent from the second quarter 2021 through the first quarter 2023, according to analysis of Private Fund Statistics. This increase has degraded the SEC’s data analysis capabilities
[22] See Final Rules at 76-77.
[23] See Final Rules at 170.
This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. © 2024 Schulte Roth & Zabel LLP. All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

Heard at the 2024 Antitrust Law Section Spring Meeting: Part II
ARTICLE / CLIENT ALERT / US POLICY
Heard at the 2024 Antitrust Law Section Spring Meeting: Part II
April 12, 2024
Read time: 10 min
The American Bar Association Antitrust Law Section’s annual Spring Meeting concluded on April 12. The annual Spring Meeting featured updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries.
This article highlights takeaways from the final two days of the Spring Meeting.
State Enforcers Remain Active
Ignore State Antitrust Enforcers at Your Own Peril
Prominent state enforcers described how they are aggressively enforcing state and federal antitrust laws by bringing cases and reaching settlements with or without a concurrent action from federal antitrust enforcement agencies. For example, state antitrust enforcers have led the way on aggressively clamping down on noncompete agreements in employment agreements and investigating and challenging no-poach agreements.
Leading antitrust enforcers from California, Maryland, Utah and Washington state touted their own statutes that prohibit or severely restrict noncompetes and other post-employment restrictive covenants. In the merger context, more states are creating “mini-HSR regimes” requiring parties to notify state antitrust enforcers of transactions in certain industries where states are especially worried about consolidation, particularly in healthcare. Several states’ mini-HSR regimes require notification of transactions that would fall below the Hart-Scott-Rodino Act (HSR) regime’s reporting threshold.
Gwendolyn Cooley, Chair of the National Association of Attorneys General Multistate Antitrust Task Force, emphasized that state attorneys general have the right to challenge mergers based on nationwide effects – not just effects within their jurisdictions.
Increased Interagency Collaboration Supports Greater State Antitrust Enforcement
State enforcers are partnering with other federal and state agencies on antitrust enforcement. For example, Schonette Jones Walker, Chief of the Antitrust Division for the Maryland Attorney General, touted a recently launched partnership between the US Department of Agriculture and several state attorneys general to protect competition and consumers in food and agricultural markets.
The Biden Administration Continues ‘Whole-of-Government’ Approach to Competition Enforcement
The Biden Administration Is All in on Interagency Cooperation
The Biden administration has taken a “whole-of-government” approach to competition policy. In the wake of the administration’s July 2021 Executive Order on Promoting Competition in the American Economy, the Federal Trade Commission (FTC) and the US Department of Justice (DOJ) have entered into numerous memorandums of understanding with industry regulators.
Mac Conforti, Assistant Chief of the DOJ Antitrust Division’s Competition Policy & Advocacy Section, explained that the “whole-of-government approach” involves both enforcement and regulation. On the enforcement front, the antitrust agencies have opened more investigations and brought more cases as a result of interagency memorandums of understanding. These agreements have fostered information sharing and case referrals across a variety of industries, including agriculture. On the regulatory front, DOJ has issued public comments on proposed regulations from non-antitrust agencies in numerous industries, with the aim of shaping regulatory frameworks that enhance competition and limit barriers to entry.
Industry Regulators Are Focused on Competition
Industry regulators are also increasing their own focus on competition in their respective sectors. For example, the Consumer Financial Protection Bureau (CFPB) has increased its cooperation with DOJ and FTC and is actively exercising its own rulemaking authority to enhance competition in consumer financial markets.
In one initiative, CFPB is promulgating rules that would enhance the portability of consumer bank account information, promoting competition from smaller banks. Likewise, the Federal Deposit Insurance Corporation (FDIC) is in the process of modifying its bank merger review process. Traditionally, the FDIC’s bank merger analysis focused on parties’ market shares for local consumer deposits; however, its new approach will focus on competition in different product lines to take a more wholistic approach to bank mergers.
Consistent Antitrust Goals Remain
At the annual Enforcers Roundtable, FTC Chair Lina Khan and DOJ Assistant Attorney General (AG) Jonathan Kanter emphasized that the end goal of antitrust enforcement remains increasing access to products and services beneficial to the lives of everyday consumers.
Across the board, enforcers highlighted healthcare and digital markets as the top areas of their current and future enforcement priorities. Additionally, Cooley, Chair of the National Association of Attorneys General Multistate Antitrust Task Force, highlighted the states’ use of state legislation and resources in collaboration with the federal antitrust enforcers to investigate complex market realities, reinforcing the “whole-of-government” approach.
Regulators Are Focused on Information Exchanges
New Technologies Must Play by Old Rules
Markus Brazill, Counsel to the Assistant Attorney General at the DOJ’s Antitrust Division, emphasized that established principles regarding collusive conduct apply the same to the “digital realm” as they do to the “physical realm.” While many have called for new guidelines on algorithmic pricing and complex data aggregation, Brazill believes the “novelty” of these emerging technologies does not change the underlying antitrust principles. If anything, new technologies “facilitate collusive practices that would otherwise not be feasible.” DOJ will continue to treat price fixing – however it is achieved – as per se unlawful.
DOJ Opines on the Withdrawal of Safety Zones for Information Sharing
When DOJ and FTC withdrew their policy statements for the healthcare industry in 2023, they withdrew safety zones for information exchanges. Brazill emphasized that the healthcare statement’s safety zones were never meant to apply outside of the healthcare industry, and the safety zones and policy statements were “formalistic and arbitrary” and “not reflective of the economics of information exchanges.”
Assistant AG Kanter opined that the withdrawn guidelines included “outdated” guidance on the use of third-party intermediaries to mitigate antitrust risk resulting from data exchanges, and that nowadays, such third parties or technology tools will “magnify” potentially anticompetitive effects. Current DOJ and FTC leadership evaluate information exchanges on a case-by-case basis, typically under the rule of reason, analyzing the nature of the market and the type of information exchanged.
Aggressive Merger Enforcement
The New Merger Guidelines Signal a More Aggressive Approach
Agency staff commented on the new Merger Guidelines and the more aggressive approach to merger enforcement that they embody.
Under the December 2023 Merger Guidelines, DOJ and FTC look at how a transaction affects the full ecosystem of trading partners – including downstream customers, upstream suppliers and rivals. The antitrust agencies are also looking to competitive harms beyond increased prices and reduced output, such as lower quality, reduced consumer choice and less innovation. In addition, the guidelines allow the agencies to look solely at direct evidence of head-to-head competition and place less reliance on industry structure.
In the annual Enforcers Roundtable, Chair Khan further noted the agencies’ intent to conform their understanding of market realities to their theories of anticompetitive harm to protect the interests of nascent and innovative competitors. Khan also opined that the contention that an acquisition of a nascent competitor by an established firm is necessary for commercialization is unconvincing when the nascent competitor is selling to a monopolist. She emphasized that it is particularly critical to consider the effects of impeding nascent competition in the pharmaceutical industry.
Negotiating Remedies: Come Prepared With a Buyer Upfront
Agency staff emphasized that it is critical for merging parties to propose remedy packages that fully address all competitive concerns. In the antitrust agencies’ view, it is not their job to assist parties with determining what remedy package will be sufficient.
The agencies recommend selecting a strong divestiture buyer upfront and providing the government with unfettered access to that buyer, allowing the agency to vet its viability. The enforcers will view access restrictions – such as the merging parties controlling what documents and information the divestiture buyer produces to the government – with a high degree of skepticism.
Merging parties should also provide the divestiture buyer with sufficient time and resources to fully evaluate the divested assets and understand how to deploy them effectively once acquired. The agencies will evaluate whether the buyer has had sufficient time to vet the divestiture package.
Challenges to Consummated Transactions Continue
Agency staff discussed recent government challenges to consummated acquisitions under both Section 7 of the Clayton Act and Section 2 of the Sherman Act. The fact that mergers have been previously notified and reviewed pursuant to the HSR Act does not preclude DOJ and FTC from later bringing actions challenging consummated transactions.
“Mergers in Disguise” Are on European Enforcers’ Radars
Competition enforcers from Brussels and Germany observed that corporations have attempted to evade merger control by, for example, lifting competitors’ staff in lieu of a formal acquisition.
Andreas Mundt, President of the German Bundeskartellamt (Federal Cartel Office), noted that these corporate maneuvers are “mergers in all but name” and “we must think about how to deal with these types of cases and think about whether legislation is needed.” Olivier Guersent, Director-General of the European Commission’s Directorate-General for Competition, noted that he has observed “relationships between large corporations and small artificial intelligence companies that conveniently never fall into the merger regulations,” further stating that he “would like to investigate whether clever lawyers deliberately planned [to evade merger regulation].”
Robinson-Patman: Restarting Enforcement?
FTC Commissioner Alvaro Bedoya Wants to Revive Robinson-Patman Enforcement
The Robinson-Patman Act prohibits price discrimination in certain circumstances. Although the law has been on the books for nearly a century, DOJ and FTC have not brought any enforcement actions under the Act in decades.
During a panel, FTC Commissioner Alvaro Bedoya expressed strong interest in bringing cases to enforce the statute, which is consistent with past comments. According to Bedoya, his priority is to “take the [Robinson-Patman Act] car out of the garage” and bring a winning case. He stated, “What happened in 1936 is happening again today. Large powerful market players are receiving secret deals smaller retailers are not, not because they’re efficient, but because they’re powerful.”
Given the antitrust agencies’ renewed interest in Robinson-Patman enforcement, companies should evaluate their pricing and trade policies to assess risk and ensure compliance.
Noncompetes and No-Poach Agreements
The Status of the Proposed Noncompete Rule Is Uncertain
In January 2023, FTC announced a Notice of Proposed Rulemaking that would ban noncompete clauses in employment contracts. The proposed rule states that noncompete provisions in employment agreements are an “unfair method of competition” under Section 5 of the FTC Act. While FTC has not disclosed when it expects the proposed rule to be finalized, the agency reiterated that it has closely reviewed more than 26,000 comments on the rule, and the final rule will incorporate the public’s feedback.
Labor Market Enforcement Is Growing Globally
Although no-poach prosecution in the US has garnered recent attention, with DOJ and private plaintiffs bringing both criminal and civil enforcement actions, other jurisdictions, such as Canada, China and Australia, have begun to follow suit, prosecuting certain no-poach and wage-fixing agreements under antitrust and competition laws akin to those of the US. Salary benchmarking, in particular, is an area of focus for global antitrust enforcers.
Consumer Protection
FTC Rulemaking Authority Remains in Use
Samuel Levine, Director of the FTC Bureau of Consumer Protection, indicated FTC’s plans to continue using its rulemaking authority to address consumer harms, which the agency views as a more effective tool than relying solely on case-by-case enforcement. The FTC highlighted its particular focus on protecting consumers in the artificial intelligence and privacy spaces. Levine said the FTC intends to bring more Section 5 claims to pursue practices harmful to consumers.

Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
ARTICLE / CLIENT ALERT
Heard at the 2024 Antitrust Law Section Spring Meeting: Part I
April 11, 2024
Read time: 9 min
The American Bar Association Antitrust Law Section’s annual Spring Meeting is underway in Washington, DC. The annual Spring Meeting features updates from federal, state and international antitrust enforcers and extensive discussion on priority antitrust issues affecting various industries.
This article highlights key takeaways from the first portion of the Spring Meeting.
Antitrust Agencies’ Priorities and Focus
Final Changes to Hart-Scott-Rodino Act (HSR) Rules Are Imminent
Deputy Assistant Attorney General (DAAG) Andrew Forman predicted that the changes to the HSR filing rules would be finalized in the coming weeks, rather than months. The final rules will be “less burdensome” than the changes that were initially proposed and have “material” differences from the proposed rules.
Information Sharing Is an “Area of Huge Interest”
Principal DAAG Doha Mekki noted that the US Department of Justice (DOJ) can draw a “straight line” between information sharing and areas where collusion has occurred. DOJ stated that the public should expect to see more enforcement activity around information sharing.
DOJ Reevaluates Its Guidance Documents
Mekki noted that DOJ’s Antitrust Division (the Division) is reevaluating whether its current guidance documents accurately reflect how the Division currently assesses competition. Mekki highlighted the July 2023 withdrawal of two antitrust policy statements related to enforcement in healthcare markets as examples of outdated guidance that the Division seeks to wipe clean.
The Division Has Many Mature Investigations Ripe for Next Steps
Mekki warned that 2024 will be busy for the Division. The Division is continuing its “whole of government approach to competition enforcement,” which entails enforcing competition laws beyond traditional Clayton and Sherman Act cases and coordinating with counterparts at other federal agencies.
Labor Markets Remain a Priority
When contemplating transactions, companies should consider not just downstream product markets but also their status as competitors for labor. The Federal Trade Commission (FTC) and DOJ (the Agencies) continue to assess competition for hiring employees when evaluating mergers, and they are not solely focused on wages, as they are also assessing overlaps in physical offices, plants and locations; commuting distances; workplace quality of life; workforce switching between companies; and impacts on unions.
DOJ Continues Pursuit of Criminal Antitrust Trials, Despite Tribulations
The Division has implemented a cultural shift in evaluating its litigation priorities. The Division now starts trial preparation the moment it initiates an investigation and has plans to staff a deep litigation bench. The Division also continues to foster relationships and partner with state enforcers in its pursuit of criminal antitrust litigation.
Preserve Ephemeral Messaging Early
DOJ Deputy Director of Civil Enforcement Suzanne Morris emphasized the agency’s position regarding firms’ obligation to preserve ephemeral documents. She said the duty to preserve kicks in when a company can “reasonably anticipate an agency investigation,” even if this occurs before the Division issues a preservation notice.
Former DAAG Andrew Finch noted that counsel should not just advise clients on this preservation practice but should also keep a careful record of such guidance and steps taken to preserve documents for agency consideration.
Expect Systematic Enforcement of Section 8 Violations Rather Than on an Ad Hoc Basis
DAAG Forman highlighted that DOJ has unwound or prevented interlocks in at least two dozen companies since it reinvigorated its enforcement of Section 8 of the Clayton Act, which prohibits competitors from sharing corporate directors or officers. DOJ specifically called out artificial intelligence as an industry that the Division is closely scrutinizing for interlocking directorates. Thus, as DOJ’s focus on Section 8 persists, proactive compliance measures are key.
Both FTC and DOJ also noted their intent to look for interlocking directorates when evaluating mergers. The Agencies warn that it is incumbent on companies to review their board membership annually, especially where private equity (PE) firms are involved. PE firms often enter new markets, and their investment typically comes with the right to appoint a board seat, which can create an interlocking director that did not previously exist. One Spring Meeting panelist stated, “An ounce of prevention is worth a pound of cure,” noting that meaningful compliance with Section 8 is paramount to smooth and efficient deal processes.
When evaluating transactions, companies should keep Section 8 in mind during the onboarding process and make sure they understand all other boards on which executives sit or plan to join.
Healthcare Transactions Remain Under “Attack”
Katrina Rouse, Health Care Counsel and Acting Deputy Director of Civil Enforcement for the Division, said DOJ is scrutinizing the healthcare industry closely given the industry’s importance to the US national economy. The Division is especially concerned about the increasing wave of vertical consolidation in the healthcare industry.
Jordan Andrew, FTC Bureau of Competition’s Deputy Assistant Director of the Mergers I Division, emphasized that transactions may result in harm to competition even when there is no commercialized product on the market, such as when two pharmaceutical or biotechnology firms are developing pipeline products but have not yet filed for or received FDA approval. FTC is carefully assessing potential competition and innovation (or research and development) competition between healthcare, pharmaceutical and biotechnology firms, and the revised Merger Guidelines provide avenues for FTC to pursue such cases.
Andrew also highlighted that FTC will continue to make use of Section 2 of the Sherman Act when challenging problematic mergers involving a monopolist. With respect to hospital mergers, FTC indicated it will make a decision to challenge the transaction regardless of whether the parties have secured a Certificate of Public Advantage. Indeed, several recent hospital merger cases demonstrate FTC’s willingness to pursue litigation in these local markets even where state antitrust enforcers support the transaction in question.
Antitrust Agencies Continue to Resist Remedies
Formal Remedy Agreements With the Agencies Are at a Historic Low
FTC and DOJ continue to express great skepticism towards remedies proposed by merging parties. The Agencies are particularly skeptical of behavioral remedies because they are complex to police and enforce. As a result, the Agencies believe consumers and the market bear the risk for these remedies failing. Rahul Rao, Deputy Director of FTC’s Bureau of Competition, emphasized that the agency is not afraid to “litigate the fix” if parties are unable to put forth satisfactory proposals for remedies. Further, Ryan Danks, Director of Civil Enforcement at DOJ’s Antitrust Division, stated that merging parties should focus on putting forward arguments for why a transaction will not harm competition without remedial measures.
Transparent, Proactive Engagement With the Agencies Is Strongly Encouraged
Acknowledging that merging parties want to have their transactions cleared, enforcers are willing to consider the merits of a transaction earlier in the process. If merging parties are willing to proactively engage with the Agencies, the enforcers will commit to providing more upfront feedback regarding their concerns with certain transactions that may present antitrust issues, which could better manage expectations for the merging parties.
To allow the Agencies to meaningfully and practically work with merging parties to remedy any potential harms to competition, however, the Agencies stress that merging parties need to be forthcoming in their remedy proposals. The Agencies ask that parties to a transaction allow potential divestiture buyers to interact with Agency staff independently, fully inform the Agencies of the competency of such buyers and evaluate – prior to filing a HSR notification – what the litigation risks are and how the transaction should be positioned before the court.
Private Equity Remains Under Agencies’ Microscope
The PE Business Model, Particularly in the Healthcare Sector, Has Attracted High Levels of Enforcement Scrutiny
Enforcers continue to remain skeptical about the procompetitive benefits of acquisitions by PE firms and question PE firms’ incentives to act as vigorous competitors.
Richard Mosier, the Division’s Special Counsel for PE, said the Division is closely scrutinizing PE acquisitions due to the use of serial acquisitions (or “roll ups”) that result in a trend toward concentration. He emphasized that roll ups can be both horizontal and vertical (such as when a firm attempts to control every part of a technology stack) and said the Division will look to challenge problematic transactions under Section 7 of the Clayton Act or Section 2 of the Sherman Act. Mosier also reminded firms that the Division will review prior non-reportable transactions.
In addition, Mosier said the Division is concerned about HSR deficiencies in the PE space (particularly when a small number of Item 4 documents are included in the filing) and questioned whether PE firms are “not taking seriously” their HSR obligations. He said the Division will not hesitate to bring cases for violations of the HSR Act, reiterating prior remarks from Ryan Danks that PE firms’ failure to comply with the HSR Act poses an “existential threat” to merger enforcement.
In light of this heightened scrutiny, PE firms should remember to fully comply with their obligations under the HSR Act.
There Is a “Cross-Government Inquiry” Into PE Transactions
As the Agencies continue to publicize their skepticism of PE deals, FTC and DOJ are taking a joint governmental approach in launching a “cross-government inquiry” into “corporate greed” in healthcare.
Because PE as an acquisition strategy is under the microscope, PE buyers should exercise diligence in preserving documents and communications in anticipation of potential investigations during or after the course of their proposed acquisitions. Panelists suggested that buyers considering serial acquisitions strategically consider completing the most critical transactions first and prepare to offer evidence that the acquisition does not substantially lessen output or quality of products and services in the relevant market.

Update of the Evidence Act – will text form be sufficient instead of written form in future?
ARTICLE
Update of the Evidence Act – will text form be sufficient instead of written form in future?
March 28, 2024
Read time: 2 min
The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “Update of the Evidence Act – Will text form be sufficient instead of written form in future?”.
Visit the blog and/or register now for regular HR NEWS updates (in German).

GDPR right of access: European supervisory authorities launch coordinated audit campaign
ARTICLE
GDPR right of access: European supervisory authorities launch coordinated audit campaign
March 18. 2024
Read time: 2 min
The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “GDPR right of access: European supervisory authorities launch coordinated audit campaign”.
Visit the blog and/or register now for regular HR NEWS updates (in German).

Shattering of the AU evidence value in the case of a precise sick note
ARTICLE
Shattering of the AU evidence value in the case of a precise sick note
March 15, 2024
Read time: 2 min
The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “Shattering of the AU evidence value in the case of a precise sick note”.
Visit the blog and/or register now for regular HR NEWS updates (in German).

Employer may refuse, but not demand repayment – No repayment claim against works council members
ARTICLE
Employer may refuse, but not demand repayment – No repayment claim against works council members
March 7, 2024
Read time: 2 min
The HR News blog provides regular updates on recent developments in German employment law (in German). The latest blog post provides insights on “Employer may refuse, but not demand repayment – No repayment claim against works council members”.
Visit the blog and/or register now for regular HR NEWS updates (in German).
